文献速递头颈US

超声引导下细针穿刺联合可选芯针活检对头颈部淋巴结和肿块的诊断效能:治疗后的鳞状细胞癌与其他病变的比较

Ultrasound-Guided Fine-Needle Aspiration With Optional Core Needle Biopsy of Head and Neck Lymph Nodes and Masses: Comparison of Diagnostic Performance in Treated Squamous Cell Cancer Versus All Other Lesions.
PubMed 文献 · J Ultrasound Med · 2018-12-28

回顾性分析861例超声引导下头颈部淋巴结和肿块活检,其中53例针对治疗后残留肿块的鳞状细胞癌(SCC)。治疗后SCC活检的诊断性病理结果率(71.7%)低于其他病变(90.7%,P < .001);在有参考标准的病例中,治疗后SCC的敏感度(87.5%)和特异度(63.6%)均低于其他病例(98.3%和99.5%)。结论认为除治疗后SCC外,该活检方法诊断效能优异;而治疗后残留SCC肿块活检非诊断样本率高、敏感度和特异度欠佳。

要点

  • 治疗后残留肿块的头颈部SCC,超声引导下穿刺活检的非诊断率较高,需警惕假阴性。
  • 治疗后SCC亚组的敏感度87.5%、特异度63.6%,均显著低于其他病变(98.3%、99.5%)。
  • 无主要并发症发生,操作安全性可接受。

核心结论

  • 排除治疗后SCC,超声引导下细针穿刺联合可选芯针活检对头颈部淋巴结和肿块具有优异的诊断效能;治疗后残留SCC肿块活检非诊断样本率高、敏感度欠佳、特异度差。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准并豁免知情同意;纳入2012年3月1日至2016年5月16日期间所有861例超声引导下头颈部淋巴结和肿块活检,以组织病理学或临床影像随访作为参考标准(在68.4%的操作中建立)。

诊断标准与关键数值

  • 在活检获得良恶性结果且有后续参考标准的病例中,治疗后SCC亚组恶性肿瘤敏感度为87.5%(95%CI 64.0%-96.5%),其他病变为98.3%(95%CI 96.0%-99.3%)(P = .047);特异度治疗后SCC为63.6%(95%CI 35.4%-84.8%),其他病变为99.5%(95%CI 97.3%-99.9%)(P < .001)。

临床应用与阅片要点

  • 对于治疗后残留肿块的头颈部SCC患者,超声引导下穿刺活检的敏感度和特异度欠佳,非诊断样本率高,可能需结合临床和影像随访综合判断。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the diagnostic performance of ultrasound (US)-guided fine-needle aspiration with optional core needle biopsy of head and neck lymph nodes and masses, with attention to differences between biopsy of treated squamous cell carcinoma (SCC) and biopsy of other lesions.

METHODS: Institutional Review Board approval was obtained, and the need for consent was waived for this retrospective study. All 861 US-guided biopsies of head and neck lymph nodes and masses performed between March 1, 2012, and May 16, 2016, were reviewed.

RESULTS: Of the 861 biopsies, 53 targeted SCC with residual masses after treatment. The biopsy procedures yielded benign or malignant pathologic results in 71.7% (38 of 53) of treated SCC and 90.7% (733 of 808) of all other lesions (P < .001). A reference standard based on subsequent pathologic results or clinical and imaging follow-up was established in 68.4% of procedures. In cases with benign or malignant biopsy results and a subsequent reference standard, the sensitivity values for malignancy were 87.5% (95% confidence interval, 64.0%-96.5%) in treated SCC and 98.3% (95% confidence interval, 96.0%-99.3%) in all other cases (P = .047), and the specificity values were 63.6% (95% confidence interval, 35.4%-84.8%) in treated SCC and 99.5% (95% confidence interval, 97.3%-99.9%) in all other cases (P < .001). There were no major complications related to the biopsy procedures.

CONCLUSIONS: Excluding treated SCC, US-guided fine-needle aspiration with optional core needle biopsy of head and neck lymph nodes and masses has excellent diagnostic performance. Needle biopsy of head and neck SCC with a residual mass after therapy has a high rate of nondiagnostic samples, suboptimal sensitivity, and poor specificity.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Wagner JM, Monfore N, McCullough AJ, et al. Ultrasound-Guided Fine-Needle Aspiration With Optional Core Needle Biopsy of Head and Neck Lymph Nodes and Masses: Comparison of Diagnostic Performance in Treated Squamous Cell Cancer Versus All Other Lesions. J Ultrasound Med. 2018. PMID: 30593702. doi:10.1002/jum.14918

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。